Acute myeloid leukemia are cancers originating from a bone marrow dysfunction. They are characterized by the uncontrolled multiplication of a category of immature white blood cells, known as “blasts”.

Significant therapeutic advances  occurred in the past two decades. However, despite these advances, the prognosis of pediatric AML remains poorer than that of other childhood leukemia subtypes.

An explanatory brochure on childhood leukemia has been developed by the ARC Foundation for Cancer Research. You can consult it directly on the ARC foundation website or by clicking here (in FR)